Table 2 Short-term clinical outcomes of chemoradiation and surgery in the mistletoe and non-mistletoe groups

Dose of radiation (Gy)

50.4

50.4

n/a

Concurrent chemotherapy

1.000^¶

 Capecitabine

15 (100)

36 (97.3)

 5-Fluorouracil

0

1 (2.7)

cT after NCRT

0.848^¶

 cT0

1 (6.7)

1 (2.7)

 cT2

6 (40.0)

12 (32.4)

 cT3

7 (46.7)

21 (56.8)

 cT4

1 (6.7)

3 (8.1)

cN after NCRT

0.666^¶

 cN0

7 (46.7)

14 (37.8)

 cN1

6 (40.0)

14 (37.8)

 cN2

2 (13.3)

9 (24.3)

Interval to surgery (weeks)

8.6 (6.1–12.9)

8.7 (5.9–14.1)

0.808^†

Type of surgery

0.506^¶

 Low anterior resection

3 (20.0)

8 (21.6)

 Ultra-low anterior resection

10 (66.7)

24 (64.9)

 Abdominoperineal resection

1 (6.7)

1 (2.7)

 Hartmann’s operation

0

3 (8.1)

 Transanal excision

1 (6.7)

1 (2.7)

Total operative time (h)

3.0 (0.8–4.1)

3.0 (0.2–5.7)

0.428^†

Estimated blood loss (mL)

20.0 (3.0–150.0)

30.0 (0–250.0)

0.385^†

Intraoperative transfusion

n/a

 Yes

0

0

 No

15 (100)

37 (100)

Length of hospital stay (days)

8 (4–37)

8 (5–51)

0.676^†